IN8bio, Inc.
USD1.54
-0.02 (-1.28%)
CEO
Tai-Wei
IPO Date
2021-07-30
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.55
Prev. Close
$1.56
Day Low
$1.48
Day High
$1.55
52W Low
$1.17
52W High
$4.17
Market Cap
$0.01B
Volume
0.10M
| 154,500 |
| $1.58 |
| 12 May 2026 | Greenwood Luba | director | A-Award | Acquired | 22,000 | $1.58 |
| 12 May 2026 | Lamb Lawrence | EVP and CSO | A-Award | Acquired | 54,000 | $1.58 |
| 12 May 2026 | FAIRBAIRN EMILY | director | A-Award | Acquired | 22,000 | $1.58 |
| 12 May 2026 | McCall Patrick | CHIEF FINANCIAL OFFICER | A-Award | Acquired | 56,250 | $1.58 |
| 12 May 2026 | Epperly Corinne | director | A-Award | Acquired | 22,000 | $1.58 |
| 12 May 2026 | Rochlin Kate | President and COO | A-Award | Acquired | 60,000 | $1.58 |
| 12 May 2026 | Brandt Peter C. | director | A-Award | Acquired | 22,000 | $1.58 |
| 12 May 2026 | Graff Jeremy R. | director | A-Award | Acquired | 22,000 | $1.58 |